Literature DB >> 28512046

Risk Factors for Preoperative Seizures and Loss of Seizure Control in Patients Undergoing Surgery for Metastatic Brain Tumors.

Adela Wu1, Jon D Weingart2, Gary L Gallia2, Michael Lim2, Henry Brem2, Chetan Bettegowda2, Kaisorn L Chaichana3.   

Abstract

OBJECTIVE: Metastatic brain tumors are the most common brain tumors in adults. Patients with metastatic brain tumors have poor prognoses with median survival of 6-12 months. Seizures are a major presenting symptom and cause of morbidity and mortality. In this article, risk factors for the onset of preoperative seizures and postoperative seizure control are examined.
METHODS: Adult patients who underwent resection of one or more brain metastases at a single institution between 1998 and 2011 were reviewed retrospectively.
RESULTS: Of 565 patients, 114 (20.2%) patients presented with seizures. Factors independently associated with preoperative seizures were preoperative headaches (P = 0.044), cognitive deficits (P = 0.031), more than 2 intracranial metastatic tumors (P = 0.013), temporal lobe location (P = 0.031), occipital lobe location (P = 0.010), and bone involvement by tumor (P = 0.029). Factors independently associated with loss of seizure control after surgical resection were preoperative seizures (P = 0.001), temporal lobe location (P = 0.037), lack of postoperative chemotherapy (P = 0.010), subtotal resection of tumor (P = 0.022), and local recurrence (P = 0.027). At last follow-up, the majority of patients (93.8%) were seizure-free. Thirty patients (5.30%) in total had loss of seizure control, and only 8 patients (1.41%) who did not have preoperative seizures presented with new-onset seizures after surgical resection of their metastases.
CONCLUSIONS: The brain is a common site for metastases from numerous primary cancers, such as breast and lung. The identification of factors associated with onset of preoperative seizures as well as seizure control postoperatively could aid management strategies for patients with metastatic brain tumors. Patients with preoperative seizures who underwent resection tended to have good seizure control after surgery.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain tumor; Cancer; Engel class; Metastatic; Seizures; Surgery

Mesh:

Year:  2017        PMID: 28512046     DOI: 10.1016/j.wneu.2017.05.028

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  13 in total

1.  Risk of Developing Postoperative Deficits Based on Tumor Location after Surgical Resection of an Intracranial Meningioma.

Authors:  Jeff S Ehresman; Tomas Garzon-Muvdi; Davis Rogers; Michael Lim; Gary L Gallia; Jon Weingart; Henry Brem; Chetan Bettegowda; Kaisorn L Chaichana
Journal:  J Neurol Surg B Skull Base       Date:  2018-07-17

Review 2.  Epilepsy in brain metastasis: an emerging entity.

Authors:  Roberta Rudà; Francesca Mo; Alessia Pellerino
Journal:  Curr Treat Options Neurol       Date:  2020-02-08       Impact factor: 3.598

3.  Antiepileptic drugs in patients with brain tumor-related epilepsy: The need for a community standard.

Authors:  Edward K Avila
Journal:  Neurooncol Pract       Date:  2021-07-28

4.  Pre-operative Seizures in Patients With Single Brain Metastasis Treated With Resection Plus Whole-Brain Irradiation and a Boost.

Authors:  Dirk Rades; Jaspar Witteler; Troels W Kjaer; Soeren Tvilsted; Steven E Schild
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

5.  Pre-Treatment Seizures in Patients With 1-3 Cerebral Metastases Receiving Local Therapies Plus Whole-brain Radiotherapy.

Authors:  Jaspar Witteler; Troels W Kjaer; Soeren Tvilsted; Steven E Schild; Dirk Rades
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

6.  Risk factors for the development of epilepsy in patients with brain metastases.

Authors:  Fabian Wolpert; Anna Lareida; Robert Terziev; Bettina Grossenbacher; Marian C Neidert; Patrick Roth; Rositsa Poryazova; Lukas L Imbach; Emilie Le Rhun; Michael Weller
Journal:  Neuro Oncol       Date:  2020-05-15       Impact factor: 12.300

7.  Seizures Among Patients with Brain Metastases: A Population- and Institutional-level Analysis.

Authors:  Nayan Lamba; Paul J Catalano; Daniel N Cagney; Daphne A Haas-Kogan; Ellen J Bubrick; Patrick Y Wen; Ayal A Aizer
Journal:  Neurology       Date:  2021-01-05       Impact factor: 9.910

8.  Postoperative seizures in meningioma patients: improving patient selection for antiepileptic drug therapy.

Authors:  Abdurrahman I Islim; Arousa Ali; Ananyo Bagchi; Mohammad U Ahmad; Samantha J Mills; Emmanuel Chavredakis; Andrew R Brodbelt; Michael D Jenkinson
Journal:  J Neurooncol       Date:  2018-06-29       Impact factor: 4.130

9.  Preoperative and early postoperative seizures in patients with glioblastoma-two sides of the same coin?

Authors:  Yahya Ahmadipour; Laurèl Rauschenbach; Alejandro Santos; Marvin Darkwah Oppong; Lazaros Lazaridis; Carlos M Quesada; Andreas Junker; Daniela Pierscianek; Philipp Dammann; Karsten H Wrede; Björn Scheffler; Martin Glas; Martin Stuschke; Ulrich Sure; Ramazan Jabbarli
Journal:  Neurooncol Adv       Date:  2020-11-18

10.  Tumor-associated epilepsy in patients with brain metastases: necrosis-to-tumor ratio forecasts postoperative seizure freedom.

Authors:  Matthias Schneider; Patrick Schuss; Majd Bahna; Muriel Heimann; Christian Bode; Valeri Borger; Lars Eichhorn; Erdem Güresir; Motaz Hamed; Ulrich Herrlinger; Yon-Dschun Ko; Felix Lehmann; Anna-Laura Potthoff; Alexander Radbruch; Christina Schaub; Rainer Surges; Johannes Weller; Hartmut Vatter; Niklas Schäfer
Journal:  Neurosurg Rev       Date:  2021-05-14       Impact factor: 2.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.